Pregnancy outcomes with donor oocyte embryos in patients diagnosed with adenomyosis using the Morphological Uterus Sonographic Assessment criteria

Objective: To use the Morphological Uterus Sonographic Assessment (MUSA) criteria to evaluate the impact of adenomyosis on the live birth rate after donor egg embryo transfer.Design: Retrospective cohort study.Setting: Tertiary fertility care center.Patient(s): A total of 100 patients who received 223 donor embryo transfers from January 2014-2020. All patients underwent ultra-sound before their first transfer.Intervention(s): None.Main Outcome Measure(s): Our study was powered (80%) to assess the primary outcome of live birth rate; the secondary outcomes included the clinical pregnancy, biochemical pregnancy, and miscarriage rates.Result(s): Only 22 of 100 patients were diagnosed with adenomyosis on the original ultrasound report. When the MUSA criteria were applied, 76 patients had at least 1 possible ultrasonographic feature of adenomyosis; all 76 patients had an interrupted junctional zone. The second most common feature of adenomyosis was a globular and/or enlarged uterus (89.4%). Adjusted modeling demonstrated that a single ultrasound feature, 2 or more features, specific features, or the location of features did not affect the live birth outcome. A per-centimeter increase in the diameter of focal lesions was significantly associated with a decrease in the odds of live birth by the factor of 0.91.Conclusion(s): To our knowledge, our study is the first to characterize adenomyosis using the MUSA criteria in the donor oocyte pop-ulation. Overall, our data were reassuring in that the ultrasonographic features of adenomyosis may not impact reproductive outcomes. However, we identified that the location and size of focal lesions may be important and should be studied further. (Fertil Steril (R) 2023;119:484-9.(c) 2022 by American Society for Reproductive Medicine.)